8TZH
Structure of full-length LRRK2 bound to MLi-2 (I2020T mutant)
Summary for 8TZH
Entry DOI | 10.2210/pdb8tzh/pdb |
Related | 8TXZ 8TZC 8TZG |
EMDB information | 41759 |
Descriptor | E11 DARPin, Leucine-rich repeat serine/threonine-protein kinase 2, (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine, ... (4 entities in total) |
Functional Keywords | gtpase, kinase, inhibitors, protein binding |
Biological source | synthetic construct More |
Total number of polymer chains | 2 |
Total formula weight | 307052.35 |
Authors | Sanz-Murillo, M.,Villagran-Suarez, A.,Alegrio Louro, J.,Leschziner, A. (deposition date: 2023-08-26, release date: 2023-12-06, Last modification date: 2023-12-13) |
Primary citation | Sanz Murillo, M.,Villagran Suarez, A.,Dederer, V.,Chatterjee, D.,Alegrio Louro, J.,Knapp, S.,Mathea, S.,Leschziner, A.E. Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures. Sci Adv, 9:eadk6191-eadk6191, 2023 Cited by PubMed: 38039358DOI: 10.1126/sciadv.adk6191 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.9 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)